EPSTEIN ROBERT S
SEC CIK 1252004 · EDGAR
BoughtSold
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
Transactions 20
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 16:55 | 2026-06-11 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +5,272 | 57.7K | +10% | $0 | |
| T | 2026-05-22 16:39 | 2026-05-20 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | S - Sale | $44.01 | -10.0K | 52.4K | -16% | -$440.1K |
| D | 2026-05-06 16:01 | 2026-05-05 | FATE | FATE THERAPEUTICS INC | EPSTEIN ROBERT S | Dir | M - OptEx | $1.69 | +25.0K | 36.3K | +221% | +$42.2K |
| D | 2025-10-03 | 2025-10-01 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | M - OptEx | $7.94 | +10.0K | 83.9K | +14% | +$79.4K |
| D | 2025-10-03 | 2025-10-01 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | S - Sale+OE | $35.08 | -21.5K | 62.4K | -26% | -$753.3K |
| 2025-06-23 | 2025-06-18 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +9,321 | 73.9K | +14% | $0 | |
| 2025-05-23 | 2025-05-21 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +3,780 | 22.1K | +21% | $0 | |
| D | 2025-01-08 | 2025-01-06 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | M - OptEx | $8.04 | +20.0K | 64.6K | +45% | +$160.8K |
| D | 2024-11-14 | 2024-11-12 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | S - Sale+OE | $38.32 | -15.0K | 44.6K | -25% | -$574.8K |
| D | 2024-11-14 | 2024-11-12 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | M - OptEx | $8.04 | +15.0K | 59.6K | +34% | +$120.6K |
| 2024-06-17 | 2024-06-13 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +11.5K | 44.6K | +35% | $0 | |
| 2024-05-17 | 2024-05-16 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +2,622 | 18.3K | +17% | $0 | |
| 2024-05-17 | 2024-05-15 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | F - Tax | $115.01 | -612 | 15.7K | -4% | -$70.4K | |
| 2023-06-13 | 2023-06-09 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +9,674 | 33.1K | +41% | $0 | |
| 2023-05-31 | 2023-05-26 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +1,532 | 16.3K | +10% | $0 | |
| D | 2023-05-25 | 2023-05-25 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | M - OptEx | $71.09 | +7,600 | 14.8K | +106% | +$540.3K |
| D | 2023-05-25 | 2023-05-24 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | F - Tax | $212.65 | -492 | 7,164 | -6% | -$104.6K |
| 2022-06-16 | 2022-06-16 | VCYT | VERACYTE, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +14.7K | 23.5K | +169% | $0 | |
| D | 2022-06-13 | 2022-06-09 | FATE | FATE THERAPEUTICS INC | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +8,650 | 11.3K | +323% | $0 |
| 2022-05-27 | 2022-05-26 | ILMN | ILLUMINA, INC. | EPSTEIN ROBERT S | Dir | A - Grant | $0.00 | +1,232 | 7,656 | +19% | $0 |
Purchase Sale Sale after option exercise All abbreviations